<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="with mild clinical manifestations; however, increased numbers of cases of" exact="microcephaly" post="and birth defects have been recently reported. To date,"/>
 <result pre="mild clinical manifestations such as fever, macular or papular rash," exact="arthritis" post="and arthralgia, nonpurulent conjunctivitis, myalgia, headache, edema, orbital pain"/>
 <result pre="observed7–9. Strong evidence suggests a link between ZIKV infection and" exact="microcephaly" post="once the viral genome has been detected in the"/>
 <result pre="metabolites13. Flavonoids are known to have antiviral activity against HIV-1," exact="herpes simplex" post="1 and 2, influenza, dengue and yellow fever14–18. Additionally,"/>
 <result pre="of flavonoids has been tested against numerous viruses such as" exact="herpes simplex" post="viruses, hepatitis B and human cytomegalovirus14,53,54. Additionally, the flavanone"/>
 <result pre="been tested against numerous viruses such as herpes simplex viruses," exact="hepatitis" post="B and human cytomegalovirus14,53,54. Additionally, the flavanone NAR presents"/>
 <result pre="viruses from the Flaviviridae family such as HCV, dengue and" exact="yellow fever" post="virus strain 17D17,18,55. It appears that some flavonoids are"/>
 <result pre="Furthermore, some treatments available for flaviviruses, like IFN-α 2A for" exact="hepatitis" post="C present several adverse effects, such as pain and"/>
 <result pre="binding, as shown for the flavonol called kaempferol against Japanese" exact="encephalitis" post="virus49. Furthermore, flavonoids seems to impair the activity of"/>
 <result pre="sequencing of Zika virus from amniotic fluid of fetuses with" exact="microcephaly" post="in Brazil: A case studyLancet Infect. Dis.201616665366010.1016/S1473-3099(16)00095-526897108 10.MS, 2018a"/>
 <result pre="Ministério da Saúde. Monitoramento dos casos de dengue, febre de" exact="chikungunya" post="e febre pelo vírus Zika até a Semana Epidemiológica"/>
 <result pre="of high pharmacological potencyBiochem. Pharmacol.19833271141114810.1016/0006-2952(83)90262-96342623 14.LyuS-YRhimJ-YParkWBAntiherpetic activities of flavonoids against" exact="herpes simplex" post="virus type 1 (HSV-1) and type 2 (HSV-2) in"/>
 <result pre="Res.2005281293130110.1007/BF0297821516350858 15.GrienkeUet al.Discovery of prenylated flavonoids with dual activity against" exact="influenza" post="virus and Streptococcus pneumoniaeSci. Rep.201662715610.1038/srep2715627257160 16.PasettoSPardiVMirataRMAnti-HIV-1 activity of flavonoid"/>
 <result pre="glycosides forms on the replication of the 17D strain of" exact="yellow fever" post="virusAv. Biomed.2014426978 18.FrabasileSet al.The citrus flavanone naringenin impairs dengue"/>
 <result pre="activity relationshipBiotechnol. Lett.20173941542110.1007/s10529-016-2261-627885509 29.DongWet al.A dual character of flavonoids in" exact="influenza" post="A virus replication and spread through modulating cell-autonomous immunity"/>
 <result pre="of chitosan nanoparticles containing naringenin and their cytotoxicity effects in" exact="lung cancer" post="cellsInt. J. Biol. Macromol.201578879510.1016/j.ijbiomac.2015.03.04525840152 51.BreinholtVMSvendsenGWDragstedLOHossainiAThe Citrus-derived Flavonoid Naringenin Exerts"/>
 <result pre="chitosan nanoparticles containing naringenin and their cytotoxicity effects in lung" exact="cancer" post="cellsInt. J. Biol. Macromol.201578879510.1016/j.ijbiomac.2015.03.04525840152 51.BreinholtVMSvendsenGWDragstedLOHossainiAThe Citrus-derived Flavonoid Naringenin Exerts"/>
 <result pre="55.GoldwasserJet al.Naringenin inhibits the assembly and long-term production of infectious" exact="hepatitis" post="C virus particles through a PPAR-mediated mechanismJ. Hepatol.20115596397110.1016/j.jhep.2011.02.01121354229 56.GoebelSet"/>
</results>
